619 related articles for article (PubMed ID: 36045401)
1. Clinical trial design in the era of precision medicine.
Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
[TBL] [Abstract][Full Text] [Related]
2. Review of precision cancer medicine: Evolution of the treatment paradigm.
Tsimberidou AM; Fountzilas E; Nikanjam M; Kurzrock R
Cancer Treat Rev; 2020 Jun; 86():102019. PubMed ID: 32251926
[TBL] [Abstract][Full Text] [Related]
3. Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design.
Fountzilas E; Tsimberidou AM; Hiep Vo H; Kurzrock R
Cancer Treat Rev; 2024 Apr; 125():102703. PubMed ID: 38484408
[TBL] [Abstract][Full Text] [Related]
4. Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform.
Said R; Tsimberidou AM
Cancer J; 2019; 25(4):282-286. PubMed ID: 31335392
[TBL] [Abstract][Full Text] [Related]
5. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
6. Innovative trial design in precision oncology.
Tsimberidou AM; Müller P; Ji Y
Semin Cancer Biol; 2022 Sep; 84():284-292. PubMed ID: 33022355
[TBL] [Abstract][Full Text] [Related]
7. New clinical trial design in precision medicine: discovery, development and direction.
Duan XP; Qin BD; Jiao XD; Liu K; Wang Z; Zang YS
Signal Transduct Target Ther; 2024 Mar; 9(1):57. PubMed ID: 38438349
[TBL] [Abstract][Full Text] [Related]
8. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
Tsimberidou AM
Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
[TBL] [Abstract][Full Text] [Related]
9. Overview of precision oncology trials: challenges and opportunities.
Fountzilas E; Tsimberidou AM
Expert Rev Clin Pharmacol; 2018 Aug; 11(8):797-804. PubMed ID: 30044653
[TBL] [Abstract][Full Text] [Related]
10. Definitions and statistical properties of master protocols for personalized medicine in oncology.
Renfro LA; Mandrekar SJ
J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
[TBL] [Abstract][Full Text] [Related]
11. Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine.
Moore DC; Guinigundo AS
J Adv Pract Oncol; 2023 Apr; 14(Suppl 1):9-13. PubMed ID: 37206904
[TBL] [Abstract][Full Text] [Related]
12. Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials.
Di Liello R; Piccirillo MC; Arenare L; Gargiulo P; Schettino C; Gravina A; Perrone F
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833129
[TBL] [Abstract][Full Text] [Related]
13. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
Tao JJ; Schram AM; Hyman DM
Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700
[TBL] [Abstract][Full Text] [Related]
14. Umbrella and basket trials in oncology: ethical challenges.
Strzebonska K; Waligora M
BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
[TBL] [Abstract][Full Text] [Related]
15. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
16. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
Ravi R; Kesari HV
Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
[TBL] [Abstract][Full Text] [Related]
17. Genomic Alteration-Driven Clinical Trial Designs in Oncology.
Simon R
Ann Intern Med; 2016 Aug; 165(4):270-8. PubMed ID: 27214515
[TBL] [Abstract][Full Text] [Related]
18. Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.
Zardavas D; Piccart-Gebhart M
Am Soc Clin Oncol Educ Book; 2015; ():e183-90. PubMed ID: 25993171
[TBL] [Abstract][Full Text] [Related]
19. New clinical trial designs in the era of precision medicine.
Garralda E; Dienstmann R; Piris-Giménez A; Braña I; Rodon J; Tabernero J
Mol Oncol; 2019 Mar; 13(3):549-557. PubMed ID: 30698321
[TBL] [Abstract][Full Text] [Related]
20. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
Albin N; Mc Leer A; Sakhri L
Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
